Rheumatoid arthritis — supplement adjuncts to DMARD therapy
For seropositive rheumatoid arthritis, DMARDs (methotrexate, leflunomide), biologics, and JAK inhibitors prevent joint destruction. Supplements do not. The supplement layer with credible adjunctive evidence — high-dose marine omega-3, bioavailable curcumin, and vitamin D in deficient patients — produces modest symptom and inflammatory-marker improvements on top of standard care, and may reduce NSAID requirements. Several "immune-stimulant" herbs commonly recommended online (echinacea, astragalus, AHCC) should be avoided in RA.
The supplement layer with credible evidence
Marine omega-3 (EPA/DHA)
2.7–3 g/day EPA+DHA
Meta-analyses (Goldberg 2007, Lee 2012) of high-dose fish oil in RA show reductions in morning stiffness duration, tender joint counts, and NSAID requirements at doses of 2.7–3 g/day EPA+DHA for 12+ weeks. Effect on RA disease-activity scores (DAS28) is modest but consistent. Reasonable adjunct that may permit NSAID tapering, with side benefits on cardiovascular risk in a population at elevated CV risk from chronic inflammation. Take with a fatty meal.
Curcumin (bioavailable form)
500–1,500 mg/day of a bioavailable formulation
Small RCTs and meta-analyses of bioavailable curcumin (Meriva, Theracurmin, BCM-95) in RA show reductions in tender/swollen joint counts, DAS28, and CRP at 500–1,500 mg/day for 8–12 weeks. Effect size is modest, with better tolerability than NSAIDs. Avoid plain turmeric powder — bioavailability is the limiting factor. Theoretical anticoagulant interaction at high doses; check with rheumatologist if on warfarin or apixaban.
Vitamin D3 (test and replete)
1,000–2,000 IU/day, titrate to 25-OH-D 30–50 ng/mL
Vitamin D deficiency is highly prevalent in RA and observationally correlates with worse disease activity. Trial evidence for disease modification on adequately-powered DAS28 is modest, but skeletal protection in patients chronically exposed to glucocorticoids is reason enough. Methotrexate users on long-term therapy have elevated osteoporosis risk and benefit from D and calcium status repletion.
Boswellia serrata
100–250 mg/day standardised to AKBA
5-LOX inhibitor with mostly OA evidence; small trials in RA show modest pain improvement. Combines well with curcumin in some integrative protocols. Effect smaller than in OA.
Folic acid (around methotrexate dose)
5 mg/week folic acid (or per rheumatologist), not on the methotrexate dose day
Routine folic acid co-prescription with methotrexate reduces nausea, mouth ulcers, transaminase elevations, and discontinuation. This is now standard of care, prescribed by the rheumatologist; mentioned here because users sometimes skip it. Take 24+ hours away from methotrexate dose. Folate-restriction approaches "to boost methotrexate efficacy" worsen tolerability without improving outcomes and are not recommended.
The Mediterranean diet pattern signal
Mediterranean-pattern diet trials in RA (Sköldstam 2003 and later) show modest reductions in disease activity and pain over 12+ weeks. The dietary pattern's anti-inflammatory profile likely contributes the same effect as the omega-3 and polyphenol supplements above but more comprehensively. Worth pursuing in parallel.
What to skip
- Echinacea, astragalus, AHCC, andrographis, beta-glucan complexes — these are immune-stimulants that may flare autoimmunity. Reasonable for cold-prevention in non-autoimmune adults; not appropriate in RA without specialist input.
- "Glandular" thyroid/adrenal preparations — irrelevant and may contain biologically active hormones.
- Cat's claw (Uncaria tomentosa) marketed for autoimmunity — old trial signal but immune-stimulant effects make this risky in RA on biologics or DMARDs.
- Stopping methotrexate or biologics to "try natural healing" — produces irreversible joint damage. The biologic-DMARD revolution is the largest reason RA outcomes have improved dramatically over 25 years.
- Spirulina or chlorella for "alkalizing" — both are immune-modulating in directions that may flare autoimmunity (case reports in lupus, MS-like exacerbations).
- Bromelain at high doses with anticoagulant DMARDs or biologics — additive bleeding risk.
- "Leaky gut" supplements (L-glutamine, marshmallow root, slippery elm at clinical doses) — leaky gut framing for RA is hypothesis-generating, not established as an intervention target.
The non-supplement layer that matters more
DMARD adherence (methotrexate, leflunomide, hydroxychloroquine, sulfasalazine), early aggressive escalation to biologics or JAK inhibitors when needed, smoking cessation (smoking accelerates RA and reduces DMARD efficacy), weight management, low-impact exercise to preserve joint range of motion, and bone-health protocol (vitamin D, calcium, bisphosphonate where indicated). The American College of Rheumatology guidelines drive the medication strategy; supplements sit alongside.